ASX - Delayed Quote AUD

Holista Colltech Limited (HCT.AX)

0.0430
+0.0020
+(4.88%)
At close: May 9 at 3:23:10 PM GMT+10
Loading Chart for HCT.AX
  • Previous Close 0.0410
  • Open 0.0410
  • Bid 0.0380 x --
  • Ask 0.0430 x --
  • Day's Range 0.0350 - 0.0430
  • 52 Week Range 0.0040 - 0.0440
  • Volume 665,043
  • Avg. Volume 206,490
  • Market Cap (intraday) 12.288M
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemic index reducer, and LOGIC, a sweetening solution alternative for health-conscious consumers. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista Colltech Limited is based in Subiaco, Australia.

www.holistaco.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HCT.AX

View More

Performance Overview: HCT.AX

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

HCT.AX
230.77%
S&P/ASX 200 [XJO] (^AXJO)
0.88%

1-Year Return

HCT.AX
330.00%
S&P/ASX 200 [XJO] (^AXJO)
6.60%

3-Year Return

HCT.AX
22.86%
S&P/ASX 200 [XJO] (^AXJO)
15.60%

5-Year Return

HCT.AX
76.11%
S&P/ASX 200 [XJO] (^AXJO)
52.68%

Compare To: HCT.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCT.AX

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    12.29M

  • Enterprise Value

    13.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.16

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.47

  • Enterprise Value/EBITDA

    47.78

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.50%

  • Return on Assets (ttm)

    3.92%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.6M

  • Net Income Avi to Common (ttm)

    -100.07k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.72k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.9k

Research Analysis: HCT.AX

View More

Company Insights: HCT.AX

Research Reports: HCT.AX

View More

People Also Watch